Insider filing · ELVN
Lori Anne Kunkel
Director
profile →
Enliven Therapeutics, Inc.
ELVN · Healthcare · 56 filings in 24 months
ticker →
Lori Anne Kunkel sold $267K of Enliven Therapeutics (ELVN)
Executed Jun 5, disclosed Jun 9, 4 days later.
Value, as filed
$267K
7,779 sh × $34.28
Executed
Jun 5
the trade date, as filed
Disclosed
Jun 9
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LKLori Anne Kunkel (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $505K of ELVN (10,000 sh across 2 lots, as filed), executed Jul 6.
The name
ELVNHealthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Lori Anne Kunkel in ELVN
ELVNSALE
Enliven Therapeutics, Inc.
$505K10,000 sh across 2 lots
Exec Jul 6
Filed Jul 8 · 5:15 PM ET